Overexpression of INHBA has been reported in several malignant tumors such as lung cancer, esophageal adenocarcinoma, gastric cancer, prostate cancer, and urothelial carcinoma [23,24,25,26,27,28]. Here, INHBA is linked to esophageal adenocarcinoma.